JBI supports WHO campaign to end malaria
World Malaria Day 2025
On World Malaria Day 2025, JBI joins the global health community in marking progress, and highlighting the urgent work that remains, to end malaria. In support of the World Health Organization’s campaign, Malaria ends with us, we spotlight an Impact Story which illustrates that when healthcare workers are supported with education and guidelines grounded in evidence, they can make a profound difference.
Malaria is life-threatening
According to the World Health Organization’s World Malaria Report 2024, there were an estimated 263 million cases of malaria and 597,000 malaria deaths globally, an increase of 11 million cases more from the previous year. Around 95% of global deaths from malaria occur in the African Region.
While progress has been made in prevention and treatment of malaria, challenges to meeting the United Nations Sustainable Development Goal (SDG) 3.3 to end the malaria epidemic by 2030, persist. The Global Fund warns that with every year that passes the fight against malaria gets harder. Climate change is a key reason, according to a paper published in The Lancet.
JBI Impact Story
The JBI Impact Story we highlight on World Malaria Day outlines an evidence implementation project that equipped rural healthcare workers in Cameroon with evidence to manage anaemia, a serious and often fatal complication of malaria in children.
By translating evidence into practice, and delivering training tailored to local needs, the project improved outcomes for some of the most vulnerable patients. The JBI Impact Story demonstrates that even in resource-limited settings, applying evidence strategically can lead to life-saving results.
JBI Evidence Summary
In addition to sharing the JBI Impact Story, we highlight a resource from the JBI EBP Database, the evidence summary, Malaria prevention in travellers. This JBI evidence summary presents the best available evidence on the safety and effectiveness of preventive medications for travellers to malaria-endemic areas.
Better evidence. Better outcomes. Brighter Future.
JBI is committed to supporting and promoting access to the best available evidence, and its implementation in practice. We are also committed to continuing our support of the World Health Organization’s efforts to end malaria. JBI reviews have informed key recommendations in the updated WHO malaria chemoprevention guidelines, including those addressing vulnerable groups like infants and pregnant women.
Today, on World Malaria Day 2025, in support of the WHO campaign Malaria ends with us, we highlight the importance of implementing evidence into practice as a critical step toward achieving sustainable progress in malaria prevention and treatment. As illustrated by JBI Impact Stories, access to relevant evidence and targeted training can strengthen healthcare delivery and improve patient outcomes, even in challenging settings.
Additional resources
